Comparative analysis of the prevalence of histopathological findings between DRESS syndrome (drug rash with eosinophilia and systemic symptoms) and drug-induced maculopapular rash: a cross-sectional study
Ludimila O. Resende, João Avancini, Marcella Soares Pincelli, Rodrigo G. Giannotti, Ana Thereza S. Casolato, Cláudia G. Santi, Marcelo A. Giannotti

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDrug-Induced Adverse Reactions · Eosinophilic Disorders and Syndromes · Pharmacovigilance and Adverse Drug Reactions
Dear Editor,
DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) is a serious adverse drug reaction characterized by fever, exanthema, and systemic involvement. Observed in 1930 in patients treated with anticonvulsants, the current term was proposed by Bocquet et al. in 1996, seeking to standardize the nomenclature and facilitate diagnosis. The estimated incidence is 1 case per 1,000 to 10,000 drug exposures, with mortality of up to 20%.1, 2, 3
Its etiopathogenesis involves hypersensitivity to drugs or their metabolites, with aromatic anticonvulsants, antidepressants, sulfonamides, nonsteroidal anti-inflammatory drugs, antibiotics, and allopurinol frequently being implicated.2, 3 The diagnosis is based on clinical-laboratory criteria, initially proposed by Bocquet et al. and subsequently refined by the European RegiSCAR score, which classifies cases as possible, probable, and definite.4
Skin biopsy can aid in diagnosis, although there is no single, specific pattern that clearly differentiates DRESS from other drug eruptions, such as maculopapular exanthema (MPE), which shares similar skin morphology but with less clinical severity.5, 6, 7
Given the scarcity of studies on the histopathological characteristics of DRESS in Latin America, this cross-sectional, retrospective, single-center study was conducted to compare the histopathological findings between confirmed and discarded cases of the syndrome, aiming to determine whether DRESS has specific pathological characteristics that allow it to be histopathologically differentiated from MPE. Forty patients hospitalized between 2008 and 2021 at Hospital das Clínicas, Faculty of Medicine, Universidade de São Paulo, were evaluated, all with clinical suspicion of drug-induced skin reaction and available skin biopsy. The medical records were reviewed for application of the RegiSCAR score, with 20 cases being classified as probable or definite DRESS (RegiSCAR > 3) and 20 as MPE (RegiSCAR ≤ 3). Additionally, a scoring system was proposed for the variables that showed a statistically significant difference between the groups, aiming to evaluate the sensitivity and specificity of the findings in distinguishing between DRESS and MPE.
Histopathological analysis was performed by two experienced dermatopathologists, and the criteria evaluated were parakeratosis, spongiosis, isolated keratinocyte necrosis, vacuolar interface dermatitis, papillary edema, pigmentary incontinence, red blood cell extravasation, eosinophilia, and inflammatory infiltrate.
The criteria were graded as described below:
Parakeratosis: Present or absent.
Spongiosis: Absent; mild (< 2/3 of the epidermis); moderate (> 2/3 and without vesiculation); intense (> 2/3 and with intraepidermal vesicles).
Isolated keratinocyte necrosis: Absent; mild (0-2/field); mild intermediate (2-5/field); moderate intermediate (5-10/field); intense (> 10/field).
Vacuolar interface dermatitis: Absent; mild (focal hydropic changes on ×400); intense (diffuse hydropic changes on ×200).
Papillary edema: Absent; mild (subtle); intense (intense with subepidermal blister formation).
Pigmentary effusion: Absent; mild (rare sparse melanophages); intense (melanophages clustered in the papillary dermis).
Hemorrhage: Absent; mild (restricted to the dermal papilla, evaluated at ×400); intense (hemorrhage extending beyond the dermal papilla, evaluated at ×200).
Eosinophilia: Absent; mild (0-10/field); moderate (10-20/field); intense (> 20/field).
Inflammatory infiltrate: Evaluated for density (absent, mild, moderate, and intense) and composition (lymphohistiocytic, neutrophilic, eosinophilic).
For the statistical analysis of these parameters, Fisher's exact test was used. Differences were considered significant if p < 0.05.
For the analysis of the proposed score, Matthews' correlation coefficient (MCC) was used, which ranges from -1 to +1, and the closer to 1, the more reliable the data obtained.
Regarding the results, a significant association was observed between DRESS and the presence of isolated keratinocyte necrosis, intense vacuolar interface dermatitis, and extensive red blood cell extravasation (all with p < 0.05). The other parameters did not differ between the groups (Table 1).Table 1. Comparative analysis of histopathological findings between the DRESS (n = 20) and drug-induced maculopapular exanthema groups. (n = 20).Table 1ParakeratosisPresentp-value (Fisher)PR (95% CI)OR (95% CI)DRESS51.001.25 (0.39‒3.99)0.75 (0.17‒3.33)Maculopapular exanthema4SpongiosisMildModeratep-value (Fisher)PR (95% CI)OR (95% CI)DRESS851.000.93 (0.60‒1.43)1.26 (0.33‒4.73)Maculopapular exanthema113Isolated keratinocyte necrosisMildMild and moderate intermediary + Intensep-value (Fisher)PR (95% CI)OR (95% CI)DRESS6110.0072.13 (1.20‒3.75)0.12 (0.03‒0.54)Maculopapular exanthema71Interface dermatitisAbsent + MildIntensep-value (Fisher)PR (95% CI)OR (95% CI)DRESS8120.0026.00 (1.54‒23.44)0.07 (0.01‒0.41)Maculopapular exanthema182Papillary dermis edemaMildIntensep-value (Fisher)PR (95% CI)OR (95% CI)DRESS640.5231.43 (0.68‒3.00)0.54 (0.15‒1.92)Maculopapular exanthema70Pigmentary incontinenceMildIntensep-value (Fisher)PR (95% CI)OR (95% CI)DRESS1031.001.00 (0.63‒1.58)1.00 (0.27‒3.67)Maculopapular exanthema130Red blood cell extravasationAbsent + MildIntensep-value (Fisher)PR (95% CI)OR (95% CI)DRESS1370.008‒0.05 (0.00‒0.89)Maculopapular exanthema200EosinophiliaMildModerateIntensep-value (Fisher)PR (95% CI)OR (95% CI)DRESS7450.3001.33 (0.88‒2.03)0.38 (0.09‒1.54)Maculopapular exanthema912Inflammatory infiltrate densityAbsent + MildModerate + Intensep-value (Fisher)PR (95% CI)OR (95% CI)DRESS6140.0562.00 (1.03‒3.88)0.23 (0.06‒0.87)Maculopapular exanthema137Inflammatory infiltrate compositionMeanDRESSMaculopapular exanthemaLymphohistiocytic87.5794.75Neutrophilic2.711.50Eosinophilic6.143.75
Regarding the proposed score, when ≥ 1 it showed 80% sensitivity and 85% specificity for the diagnosis of DRESS, and ≥ 2 had 100% specificity. The MCC was 0.65 for a 1-point score and 0.58 for a 2-point score (Table 2).Table 2. Proposed scoring system for differentiating between DRESS and drug-induced maculopapular exanthema, based on three criteria: intense interface dermatitis (0 or 1-point), intense red blood cell extravasation (0 or 1-point), and keratinocyte necrosis (0 or 1-point – isolated or 2-points – extensive). The total score ranges from 0 to 4.Table 21-point rule0≥ 1TotalDRESS41620Specificity0.85Maculopapular exanthema17320Sensitivity0.80Total211940PPV0.81NPV0.84Accuracy0.83MCC0.652-point rule0≥2TotalDRESS101020Specificity1.00Maculopapular exanthema20020Sensitivity0.50Total301040PPV0.67NPV1.00Accuracy0.75MCC0.58PPV, Positive Predictive Value; NPV, Negative Predictive Value; MCC, Matthews Correlation Coefficient.
The results obtained in this study corroborate previous findings in the literature that indicate that keratinocyte necrosis and interface lesions are frequent markers in DRESS. Overall, interface dermatitis is the most common histopathological presentation reported in the literature, having been found in more than three-quarters of patients with DRESS in previous studies.7
The presence of extravasation of red blood cells, possibly resulting from endothelial damage, also stood out as a discriminatory criterion, reinforcing the hypothesis that the dermal endothelium is a frequent target of DRESS.5, 6, 7, 8
Although eosinophilia is an important diagnostic criterion in peripheral blood, eosinophilic tissue infiltration did not show correlation with the severity of the condition, both in the present study and in previous analyses; that is, more severe phenotypes did not show a higher density of eosinophilic tissue infiltrate.5
As for spongiosis, described in up to 80% of cases in other publications and correlated with favorable outcomes in DRESS,7, 8 was not statistically significant in the present sample, which may be attributed to the temporal variability between the appearance of lesions and the biopsy performance, and to the sample size.
The study by Cho et al.7 demonstrated that the coexistence of three histological patterns (eczematous, interface dermatitis, and vascular damage) is more common in definitive cases of DRESS, being associated with greater clinical and hematological severity. The observation of multiple patterns was also present in part of the present sample, although it was not formally quantified.
Regarding the study limitations, it is a retrospective study, dependent on the analysis of medical records (which are not always complete); it has a medium sample size, which impacts the statistical analysis; and it has a variation between the time of lesion evolution and the biopsy performance, which affects the histopathological findings.
In conclusion, the present study demonstrated that, when comparing patients with DRESS and MPE, the presence of isolated keratinocyte necrosis, intense vacuolar interface dermatitis, and extensive red blood cell extravasation was significantly higher in the first group. Furthermore, the proposed score has relevant discriminatory potential, but its diagnostic application requires validation in independent cohorts and in different centers.
ORCID ID
João Avancini: 0000-0003-3038-6373
Marcella Soares Pincelli: 0000-0001-9754-0705
Rodrigo G. Giannotti: 0009-0003-9456-2871
Ana Thereza S. Casolato: 0000-0002-4858-4258
Cláudia G. Santi: 0000-0003-3650-4254
Marcelo A. Giannotti: 0000-0002-8911-6020
Research data availability
The entire dataset supporting the results of this study was published in this article.
Financial support
None declared.
Authors' contributions
Ludimila O. Resende: Collection, analysis, and interpretation of data; Critical review of the literature; drafting and editing of the manuscript; approval of the final version of the manuscript.
João Avancini: Design and planning of the study; Effective participation in research orientation; Intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; Approval of the final version of the manuscript.
Marcella Soares Pincelli: Critical review of the manuscript; Interpretation of histopathological data.
Rodrigo G. Giannotti: Statistical analysis; Table preparation.
Ana Thereza S. Casolato: Collection, analysis, and interpretation of data.
Cláudia G. Santi: Approval of the final version of the manuscript; Critical review of the content.
Marcelo A. Giannotti: Effective participation in research orientation; Critical review of the manuscript; Approval of the final version of the manuscript; Interpretation of histopathological data.
Conflicts of interest
None declared.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Bocquet H.Bagot M.Roujeau J.C.Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)Semin Cutan Med Surg.151996250257906959310.1016/s 1085-5629(96)80038-1 · doi ↗ · pubmed ↗
- 2Cho Y.T.Yang C.W.Chu C.Y.Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system Int J Mol Sci.18201712432859836310.3390/ijms 18061243 PMC 5486066 · doi ↗ · pubmed ↗
- 3Criado P.R.Ianhez M.Miot H.A.Criado R.F.J.Talhari C.Müller Ramos P.DRESS syndrome: an interaction between drugs, latent viruses, and the immune system An Bras Dermatol.10020251041203952170810.1016/j.abd.2023.12.010PMC 11745295 · doi ↗ · pubmed ↗
- 4Kardaun S.H.Sekula P.Valeyrie-Allanore L.Liss Y.Chu C.Y.Creamer D.Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction Br J Dermatol.15620076096112385531310.1111/bjd.12501 · doi ↗ · pubmed ↗
- 5Ortonne N.Valeyrie-Allanore L.Bastuji-Garin S.Wechsler J.de Feraudy S.Duong T.A.Histopathology of drug rash with eosinophilia and systemic symptoms: a morphological study of 45 cases Br J Dermatol.173201550582563079610.1111/bjd.13683 · doi ↗ · pubmed ↗
- 6Chi M.H.Hui R.C.Yang C.H.Lin J.Y.Lin Y.T.Ho H.C.Histopathological characteristics of drug reaction with eosinophilia and systemic symptoms: clues to early diagnosis Br J Dermatol.17020148668732432910510.1111/bjd.12783 · doi ↗ · pubmed ↗
- 7Cho Y.T.Liau J.Y.Chang C.Y.Yang C.W.Chen K.L.Chen Y.C.Co-existence of histopathological features is characteristic in drug reaction with eosinophilia and systemic symptoms and correlates with high grades of cutaneous abnormalities J Eur Acad Dermatol Venereol.302016207720842722569510.1111/jdv.13728 · doi ↗ · pubmed ↗
- 8Skowron F.Bensaid B.Balme B.Depaepe L.Kanitakis J.Nosbaum A.Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases J Eur Acad Dermatol Venereol.292015219922052635473410.1111/jdv.13212 · doi ↗ · pubmed ↗
